Status:

NOT_YET_RECRUITING

Histological Evaluation in the Efficacy of GentleWave in Root Canal Pulp Tissue Debridement and Disinfection of Difficult to Reach Areas in Mandibular Human Molars II. An In-vivo Study.

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborating Sponsors:

Sonendo, Inc.

Conditions:

Root Canal Treatment

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The purpose of this study is to understand and learn better the efficacy of GentleWave and obtain histological evidence of the efficacy of this new technology done in-vivo

Eligibility Criteria

Inclusion

  • Only teeth that patient decided to have the extraction done instead of having any other type of dental treatment and teeth extracted at patient's petition.

Exclusion

  • Teeth with root fractures or previously root canal treated teeth.
  • Teeth with severe loss of structure
  • Children

Key Trial Info

Start Date :

November 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04105907

Start Date

November 1 2025

End Date

November 1 2026

Last Update

September 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030